ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: HHMI Commits $300M To Support Early Career Scientists.

March 21, 2008

Regulatory Approvals: Gardasil 9 approved, which covers five additional HPV types

December 12, 2014

Funding Opportunities: NCI Schedules Meeting on RFA For Pathology Informatics

May 12, 2000

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

Professional Fundraiser Poses Eight Questions For SU2C 3.

September 19, 2008

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013